Macrophage T lymphocyte interactions in the anti-tumor immune response: a mathematical model
- PMID: 3156189
Macrophage T lymphocyte interactions in the anti-tumor immune response: a mathematical model
Abstract
In this paper we present a model of the macrophage T lymphocyte interactions that generate an anti-tumor immune response. The model specifies i) induction of cytotoxic T lymphocytes, ii) antigen presentation by macrophages, which leads to iii) activation of helper T cells, and iv) production of lymphoid factors, which induce a) cytotoxic macrophages, b) T lymphocyte proliferation, and c) an inflammation reaction. Tumor escape mechanisms (suppression, antigenic heterogeneity) have been deliberately omitted from the model. This research combines hitherto unrelated or even contradictory data within the range of behavior of one model. In the model behavior, helper T cells play a crucial role: Tumors that differ minimally in antigenicity (i.e., helper reactivity) can differ markedly in rejectability. Immunization yields protection against tumor doses that would otherwise be lethal, because it increases the number of helper T cells. The magnitude of the cytotoxic effector cell response depends on the time at which helper T cells become activated: early helper activity steeply increases the magnitude of the immune response. The type of cytotoxic effector cells that eradicates the tumor depends on tumor antigenicity: lowly antigenic tumors are attacked mainly by macrophages, whereas large highly antigenic tumors can be eradicated by cytotoxic T lymphocytes only.
Similar articles
-
Concomitant immunization by the fully antigenic counterparts prevents modulated tumor cells from escaping cellular immune elimination.J Immunol. 1986 Jun 1;136(11):4319-27. J Immunol. 1986. PMID: 2939142
-
Killer-helper effect of L cells in the generation of anti-MM cytotoxic T lymphocytes: replacement by beta-interferon and mechanisms of action.Jpn J Cancer Res. 1986 Sep;77(9):931-40. Jpn J Cancer Res. 1986. PMID: 2945807
-
Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2.J Immunol. 1981 Mar;126(3):1120-5. J Immunol. 1981. PMID: 6161959
-
Mechanisms of mouse T lymphocyte-induced suppression of the IgG2ab allotype and T lymphocyte tolerance to IgG2ab.Arch Immunol Ther Exp (Warsz). 2001;49(6):407-15. Arch Immunol Ther Exp (Warsz). 2001. PMID: 11814234 Review.
-
Role of macrophages in the expression of immune responses.J Am Vet Med Assoc. 1982 Nov 15;181(10):1037-42. J Am Vet Med Assoc. 1982. PMID: 6757210 Review.
Cited by
-
A survey of some formal models in tumor immunology.Cancer Immunol Immunother. 1986;23(3):159-64. doi: 10.1007/BF00205644. Cancer Immunol Immunother. 1986. PMID: 3491679 Free PMC article.
-
Predicting immune checkpoint inhibitor response with mathematical modeling.Immunotherapy. 2021 Oct;13(14):1151-1155. doi: 10.2217/imt-2021-0209. Epub 2021 Aug 26. Immunotherapy. 2021. PMID: 34435504 Free PMC article. No abstract available.
-
The impact of tumor associated macrophages on tumor biology under the lens of mathematical modelling: A review.Front Immunol. 2022 Nov 10;13:1050067. doi: 10.3389/fimmu.2022.1050067. eCollection 2022. Front Immunol. 2022. PMID: 36439180 Free PMC article. Review.
-
Fine-tuning anti-tumor immunotherapies via stochastic simulations.BMC Bioinformatics. 2012 Mar 28;13 Suppl 4(Suppl 4):S8. doi: 10.1186/1471-2105-13-S4-S8. BMC Bioinformatics. 2012. PMID: 22536975 Free PMC article.
-
Mathematical model of tumor-macrophage dynamics in glioma to advance myeloid-targeted therapies.bioRxiv [Preprint]. 2025 Jul 18:2025.07.14.664717. doi: 10.1101/2025.07.14.664717. bioRxiv. 2025. Update in: Comput Biol Med. 2025 Aug 21;196(Pt C):110909. doi: 10.1016/j.compbiomed.2025.110909. PMID: 40791528 Free PMC article. Updated. Preprint.